7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.

about

Marketing approval of mogamulizumab: a triumph for glyco-engineering.Fourth World Antibody-Drug Conjugate Summit: February 29-March 1, 2012, Frankfurt, Germany.Mabs's communication networks.Antibody-drug conjugates: present and future.

P2860

Q42333453-D52B84A6-302B-426C-A428-F2DE41887C77 Q42337744-4FF0E68F-76E8-4B71-94D1-5D3A8458DE1E Q43183813-34329ABE-0C04-4D5A-929A-7611C8ABB6CA Q51317043-F56CA56B-F2E3-41FE-9737-B1A85400546B

P2860

7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.

Item

http://www.wikidata.org/entity/Q35992488

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

7th annual European Antibody C ...... 1, 2011, Geneva, Switzerland.

@ast

7th annual European Antibody C ...... 1, 2011, Geneva, Switzerland.

@en

type

Item

label

7th annual European Antibody C ...... 1, 2011, Geneva, Switzerland.

@ast

7th annual European Antibody C ...... 1, 2011, Geneva, Switzerland.

@en

prefLabel

7th annual European Antibody C ...... 1, 2011, Geneva, Switzerland.

@ast

7th annual European Antibody C ...... 1, 2011, Geneva, Switzerland.

@en

P1476

7th annual European Antibody C ...... r 1, 2011, Geneva, Switzerland

@en

P2093

Alain Beck

http://www.w3.org/2001/XMLSchema#string

Alexey A Lugovskoy

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

A highly conserved neutralizing epitope on group 2 influenza A viruses

Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor

Epitope characterization and crystal structure of GA101 provide insights into the molecular basis for type I/II distinction of CD20 antibodies

Bispecific digoxigenin-binding antibodies for targeted payload delivery

Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Acceptable changes in quality attributes of glycosylated biopharmaceuticals

P304

134-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/MABS.4.2.19426

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Janice M. Reichert

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221978093

http://www.w3.org/2001/XMLSchema#string

P698

22453093

http://www.w3.org/2001/XMLSchema#string

P932

3361652

http://www.w3.org/2001/XMLSchema#string

7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.

about

P2860

P2860

7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932